Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05655156Not ApplicableRecruiting

OrthoPureXT Multiligament PMCF Study

Role: lead

NCT02540811Not ApplicableCompleted

Clinical Evaluation of dCELL® ACL Scaffold for Reconstruction of the Anterior Cruciate Ligament

Role: lead

NCT03939715Phase 4Unknown

Surgical Intervention With DermaPure vs Native Tissue in Pelvic Organ Prolapse

Role: collaborator

NCT02270905Not ApplicableSuspended

Clinical Evaluation of dCELL® Meniscus for Partial Replacement of the Meniscus

Role: lead

NCT00958230Not ApplicableCompleted

dCell Vascular Patch in Peripheral Vascular Surgery Study for CE Mark Submission

Role: lead

All 5 trials loaded